Department of the Army January 25, 2010 – Federal Register Recent Federal Regulation Documents
Results 1 - 2 of 2
Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Monoclonal Antibodies Against Glycoprotein of Ebola Sudan Boniface Virus
Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/290,725 entitled ``Monoclonal Antibodies Against Glycoprotein of Ebola Sudan Boniface Virus,'' filed December 29, 2009. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
Board of Visitors, United States Military Academy (USMA)
Under the provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix, as amended), the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-3.150, the Department of Defense announces that the following Federal advisory committee meeting will take place:
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.